Chemotherapy in advanced ovarian cancer
- 1 April 1984
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 107 (2), 99-105
- https://doi.org/10.1007/bf00399380
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?The Lancet, 1983
- Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian CancerNew England Journal of Medicine, 1982
- Male Pseudohermaphroditism with 17α‐Hydroxylase DeficiencyBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycinCancer, 1980
- Cytoreductive Surgical Treatment In the Management of Advanced Ovarian CancerPublished by Springer Nature ,1980
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Acute Leukemia after Alkylating-Agent Therapy of Ovarian CancerNew England Journal of Medicine, 1977
- The chemotherapy of ovarian carcinomaCancer Treatment Reviews, 1974